Liver fibrosis evaluation in lean steatotic liver disease patients

被引:0
|
作者
Testino, Gianni [1 ,2 ,3 ]
机构
[1] ASL3 Liguria, IRCCS San Martino Univ Hosp, Alcohol Reg Ctr, Unit Addict & Hepatol, Piazzale R Benzi 10, I-16132 Genoa, Italy
[2] ASL3 Liguria, Ctr Studi Mutual Self Help, Genoa, Italy
[3] ASL3, Dept Hlth Lifestyles, Genoa, Italy
来源
关键词
D O I
10.23736/S2724-5985.24.03686-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature
    Ma, Ning
    Bansal, Meena
    Chu, Jaime
    Branch, Andrea D.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (02): : 229 - 237
  • [32] Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
    Wakabayashi, Shun-Ichi
    Tamaki, Nobuharu
    Kimura, Takefumi
    Umemura, Takeji
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (06) : 494 - 503
  • [33] Treatment of HCV infection in patients with steatotic liver disease
    Flisiak, Robert
    Zarebska-Michaluk, Dorota
    Dobrowolska, Krystyna
    Janocha-Litwin, Justyna
    Dybowska, Dorota
    Sitko, Marek
    Socha, Lukasz
    Lorenc, Beata
    Klapaczynski, Jakub
    Brodowski, Jakub
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 10 (03) : 159 - 164
  • [34] Association between liver fibrosis, mental health, and lifestyle behaviors in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Robertson, Tayla
    Hamdan, Nashla
    Bera, Chinmay
    Kuczynski, Magdalena
    Pakseresht, Radin
    Chen, Bo
    Patel, Keyur
    JOURNAL OF HEPATOLOGY, 2024, 80 : S497 - S497
  • [35] The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease
    Lee, Hye Won
    Kim, Kun Hee
    Ahn, Sang Hoon
    Lee, Han Chu
    Choi, Jonggi
    LIVER INTERNATIONAL, 2024, 44 (06) : 1448 - 1455
  • [36] Multiparametric ultrasound evaluation of liver fibrosis, steatosis, and viscosity in patients with chronic liver disease
    Minciuna, Iulia
    Taru, Madalina
    Fodor, Andreea
    Farcau, Oana Nicoara
    Fischer, Petra
    Radu, Corina
    Lupsor-Platon, Monica
    Stefanescu, Horia
    Procopet, Bogdan
    MEDICAL ULTRASONOGRAPHY, 2024, 26 (02) : 117 - 124
  • [37] The performance of the enhanced liver fibrosis test by cardiometabolic risk factors in patients with metabolic dysfunction-associated steatotic liver disease
    Kawata, Kazuhito
    Takahashi, Hirokazu
    Arai, Taeang
    Seko, Yuya
    Chida, Takeshi
    Noritake, Hiedenao
    Toyoda, Hidenori
    Hayashi, Hideki
    Yamaguchi, Kanji
    Iwaki, Michihiro
    Yoneda, Masato
    Shima, Toshihide
    Fujii, Hideki
    Morishita, Asahiro
    Tomita, Kengo
    Kawanaka, Miwa
    Yoshida, Yuichi
    Ikegami, Tadashi
    Notsumata, Kazuo
    Oeda, Satoshi
    Atsukawa, Masanori
    Kamada, Yoshihiro
    Sumida, Yoshio
    Fukushima, Hideaki
    Miyoshi, Eiji
    Aishima, Shinichi
    Okanoue, Takeshi
    Itoh, Yoshito
    Nakajima, Atsushi
    JOURNAL OF HEPATOLOGY, 2024, 80 : S537 - S538
  • [38] LONG-TERM LIVER-RELATED OUTCOMES AND LIVER FIBROSIS PROGRESSION OF STATIN USAGE IN STEATOTIC LIVER DISEASE
    Zhou, Xiao-Dong
    Kim, Seung Up
    Yip, Terry Cheuk-Fung
    Petta, Salvatore
    Nakajima, Atsushi
    Tsochatzis, Emmanuel
    Boursier, Jerome
    Bugianesi, Elisabetta
    Hagstrom, Hannes
    Chan, Wah-Kheong
    Romero-Gomez, Manuel
    Luis Calleja, Jose
    de Ledinghen, Victor
    Castera, Laurent
    Sanyal, Arun J.
    Goh, George Boon-Bee
    Newsome, Philip N.
    Fan, Jian-Gao
    Lai, Michelle
    Fournier Poizat, Celine
    Lee, Hye Won
    Wong, Grace
    Armandi, Angelo
    Shang, Ying
    Pennisi, Grazia
    Llop, Elba
    Yoneda, Masato
    de Saint-Loup, Marc
    Canivet, Clemence
    Lara-Romero, Carmen
    Gallego-Duran, Rocio
    Asgharpour, Amon
    Teh, Kevin Kim-Jun
    Mahgoub, Sara
    Chan, Mandy Sau-Wai
    Lin, Huapeng
    Liu, Wenyue
    Targher, Giovanni
    Byrne, Christopher
    Wong, Vincent Wai-Sun
    Zheng, Ming-Hua
    HEPATOLOGY, 2024, 80 : S2000 - S2001
  • [39] Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3
    Ichikawa, Tatsuki
    Yamashima, Mio
    Yamamichi, Shinobu
    Koike, Makiko
    Nakano, Yusuke
    Yajima, Hiroyuki
    Miyazaki, Osamu
    Ikeda, Tomonari
    Okamura, Takuma
    Komatsu, Naohiro
    Sugio, Sayuri
    Yoshino, Miruki
    Miyaaki, Hisamitsu
    INTERNAL MEDICINE, 2024,
  • [40] High prevalence of liver fibrosis and cirrhosis among cohort of patients referred to an urban liver centre for evaluation of metabolic dysfunction-associated steatotic liver disease (utility of transient elastography)
    Jammu, Anish
    Xu, Jason
    Rais, Josh
    Shpilevaia, Elizaveta
    Ghafoor, Aleena
    Ali, Farah Imdad
    Pavic, Eva
    Fragoso, Eva
    Modarresi, Mehrdad
    Magnes, Marzena
    Elkhashab, Magdy
    JOURNAL OF HEPATOLOGY, 2024, 80 : S561 - S561